Home Healthcare Biotechnology Prostate Cancer Diagnostics Market

Prostate Cancer Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Preliminary Tests, Confirmatory Tests), By Type (Adenocarcinoma, Interstitial Cell Carcinoma, Other), By End Use (Hospitals, Outpatient Facilities, Home Care, Others) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: July 09, 2026 | Author: Debashree B | Format: | Report Code: SR4791DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Prostate Cancer Diagnostics Market Size Analysis
    1. Introduction
    2. Prostate Cancer Diagnostics Market Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
      1. Preliminary Tests
        1. PSA Tests
        2. Free PSA Test
        3. Total PSA Test
        4. Other Preliminary Tests
      2. Confirmatory Tests
        1. Pca3 Test
        2. Trans-Rectal Ultrasound
        3. Biopsy Test
    3. Prostate Cancer Diagnostics Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Adenocarcinoma
      2. Interstitial Cell Carcinoma
      3. Other
    4. Prostate Cancer Diagnostics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Outpatient Facilities
      3. Home Care
      4. Others
  7. North America Prostate Cancer Diagnostics Market Size Analysis
    1. Introduction
    2. Prostate Cancer Diagnostics Market Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
      1. Preliminary Tests
        1. PSA Tests
        2. Free PSA Test
        3. Total PSA Test
        4. Other Preliminary Tests
      2. Confirmatory Tests
        1. Pca3 Test
        2. Trans-Rectal Ultrasound
        3. Biopsy Test
    3. Prostate Cancer Diagnostics Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Adenocarcinoma
      2. Interstitial Cell Carcinoma
      3. Other
    4. Prostate Cancer Diagnostics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Outpatient Facilities
      3. Home Care
      4. Others
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
  8. Europe Prostate Cancer Diagnostics Market Size Analysis
    1. Introduction
    2. Prostate Cancer Diagnostics Market Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
      1. Preliminary Tests
        1. PSA Tests
        2. Free PSA Test
        3. Total PSA Test
        4. Other Preliminary Tests
      2. Confirmatory Tests
        1. Pca3 Test
        2. Trans-Rectal Ultrasound
        3. Biopsy Test
    3. Prostate Cancer Diagnostics Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Adenocarcinoma
      2. Interstitial Cell Carcinoma
      3. Other
    4. Prostate Cancer Diagnostics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Outpatient Facilities
      3. Home Care
      4. Others
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    7. France
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
  9. APAC Prostate Cancer Diagnostics Market Size Analysis
    1. Introduction
    2. Prostate Cancer Diagnostics Market Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
      1. Preliminary Tests
        1. PSA Tests
        2. Free PSA Test
        3. Total PSA Test
        4. Other Preliminary Tests
      2. Confirmatory Tests
        1. Pca3 Test
        2. Trans-Rectal Ultrasound
        3. Biopsy Test
    3. Prostate Cancer Diagnostics Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Adenocarcinoma
      2. Interstitial Cell Carcinoma
      3. Other
    4. Prostate Cancer Diagnostics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Outpatient Facilities
      3. Home Care
      4. Others
    5. China
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    8. India
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    10. Singapore
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
  10. Middle East and Africa Prostate Cancer Diagnostics Market Size Analysis
    1. Introduction
    2. Prostate Cancer Diagnostics Market Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
      1. Preliminary Tests
        1. PSA Tests
        2. Free PSA Test
        3. Total PSA Test
        4. Other Preliminary Tests
      2. Confirmatory Tests
        1. Pca3 Test
        2. Trans-Rectal Ultrasound
        3. Biopsy Test
    3. Prostate Cancer Diagnostics Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Adenocarcinoma
      2. Interstitial Cell Carcinoma
      3. Other
    4. Prostate Cancer Diagnostics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Outpatient Facilities
      3. Home Care
      4. Others
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
  11. LATAM Prostate Cancer Diagnostics Market Size Analysis
    1. Introduction
    2. Prostate Cancer Diagnostics Market Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
      1. Preliminary Tests
        1. PSA Tests
        2. Free PSA Test
        3. Total PSA Test
        4. Other Preliminary Tests
      2. Confirmatory Tests
        1. Pca3 Test
        2. Trans-Rectal Ultrasound
        3. Biopsy Test
    3. Prostate Cancer Diagnostics Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Adenocarcinoma
      2. Interstitial Cell Carcinoma
      3. Other
    4. Prostate Cancer Diagnostics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Outpatient Facilities
      3. Home Care
      4. Others
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Test Type 2022-2034 (USD MILLION/ Units)
        1. Preliminary Tests
          1. PSA Tests
          2. Free PSA Test
          3. Total PSA Test
          4. Other Preliminary Tests
        2. Confirmatory Tests
          1. Pca3 Test
          2. Trans-Rectal Ultrasound
          3. Biopsy Test
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Adenocarcinoma
        2. Interstitial Cell Carcinoma
        3. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Outpatient Facilities
        3. Home Care
        4. Others
  12. Competitive Landscape
    1. Prostate Cancer Diagnostics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. MDx Health
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Myriad Genetics, Inc.
    3. Abbott Laboratories
    4. Hoffman-La Roche AG
    5. Bayer AG
    6. Siemens Healthcare GmbH
    7. OPKO Health, Inc.
    8. Genomic Health.
    9. Pfizer Inc.
    10. Proteomedix
    11. Beckman Coulter, Inc.
    12. Quest Diagnostics
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.